BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35798133)

  • 21. Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation.
    Jiang X; Otterdal K; Chung BK; Maucourant C; Rønneberg JD; Zimmer CL; Øgaard J; Boichuk Y; Holm S; Geanon D; Schneditz G; Bergquist A; Björkström NK; Melum E
    Gastroenterology; 2024 Apr; 166(4):667-679. PubMed ID: 37995866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
    Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
    Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of primary sclerosing cholangitis.
    Pollheimer MJ; Halilbasic E; Fickert P; Trauner M
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):727-39. PubMed ID: 22117638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Zecher BF; Ellinghaus D; Schloer S; Niehrs A; Padoan B; Baumdick ME; Yuki Y; Martin MP; Glow D; Schröder-Schwarz J; Niersch J; Brias S; Müller LM; Habermann R; Kretschmer P; Früh T; Dänekas J; Wehmeyer MH; Poch T; Sebode M; ; Ellinghaus E; Degenhardt F; Körner C; Hoelzemer A; Fehse B; Oldhafer KJ; Schumacher U; Sauter G; Carrington M; Franke A; Bunders MJ; Schramm C; Altfeld M
    Gut; 2024 Jan; 73(2):325-337. PubMed ID: 37788895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic bile duct loss in primary sclerosing cholangitis: a quantitative study.
    Casali AM; Carbone G; Cavalli G
    Histopathology; 1998 May; 32(5):449-53. PubMed ID: 9639121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis.
    Li Y; Li B; Xiao X; Qian Q; Wang R; Lyu Z; Chen R; Cui N; Ou Y; Pu X; Miao Q; Wang Q; Lian M; Gershwin ME; Tang R; Ma X; You Z
    Hepatology; 2024 Jan; 79(1):25-38. PubMed ID: 37505225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic segmental primary sclerosing cholangitis: report of a case.
    Matsumoto T; Ajiki T; Matsumoto I; Tominaga M; Hori H; Mita Y; Fujita T; Fujino Y; Suzuki Y; Ku Y; Kuroda Y
    Surg Today; 2006; 36(7):638-41. PubMed ID: 16794801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
    Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
    JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
    J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of the murine biliopancreatic tract at 7 Tesla: technique and results in a model of primary sclerosing cholangitis.
    Ernst TM; Schwinge D; Raabe N; Daubmann A; Kaul MG; Adam G; Schramm C; Ittrich H
    J Magn Reson Imaging; 2014 Dec; 40(6):1355-64. PubMed ID: 24227696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
    Gauss A; Sauer P; Stiehl A; Rupp C; Krisam J; Leopold Y; Kloeters-Plachky P; Stremmel W; Gotthardt D
    Medicine (Baltimore); 2016 Apr; 95(17):e3510. PubMed ID: 27124059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristic Findings of Primary Sclerosing Cholangitis on Endoscopic Retrograde Cholangiography: Which is the Most Common Finding?
    Mohammad Alizadeh AH; Shahnazi A; Rasoulzadeh A; Shams E; Mohammadi M; Darabi F; Behdad M
    Clin Med Insights Gastroenterol; 2012; 5():1-4. PubMed ID: 24833928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
    Nguyen L; Cazzagon N; Corpechot C; El Mouhadi S; Lemoinne S; Chazouillères O; Arrivé L
    Eur Radiol; 2019 Mar; 29(3):1460-1468. PubMed ID: 30159619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
    Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
    J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
    Washington K; Clavien PA; Killenberg P
    Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.